 |
* Requires

|
|
 |
FUTURE ONCOLOGY
Volume 7 #1/2 August 31, 2002
Anticancer Drugs and Markets
UPDATE ON SPINDLE POISONS - PART III NOVEL AGENTS IN DEVELOPMENT
NOVEL MICROTUBULE STABILIZING COMPOUNDS OBTAINED FROM NATURAL SOURCES-EXTRACTS, AND SEMISYNTHETIC AND SYNTHETIC ANALOGS
- Colchicine-site Binders
- Combretastatins
- AVE806
- Combretastatin A-4 prodrug (CA4P)
- Oxi-4503
- Cryptophycins
- Discodermolide
- Dolastatin and Analogs
- Auristatin PHE
- Dolastatin 10
- ILX-651
- Symplostatin 1
- TZT-1027
- Epothilones
- BMS-247550
- BMS-310705
- EPO906
- KOS-862
- ZK-EPO
- Eleutherobin
- FR182877
- Halichondrin B
- Halimide
- Hemiasterlins
- Laulimalide
- Maytansinoids
- Bivatuzumab mertansine
- Cantuzumab mertansine
- huN901-DM1/BB-10901TAP
- MLN591DM1
- My9-6-DM1
- Trastuzumab-DM1
- PC-SPES
- Peloruside A
- Resveratrol
- S-allylmercaptocysteine (SAMC)
- Spongistatins
- Vitilevuamide
MOLECULAR MOTOR-KINESINS
DESIGNED COLCHICINE-SITE BINDERS
- A-289099
- A-293620/A-318315
- ABT-751/E7010
- D-24851/D-64131
- ZD6126
OTHER NOVEL SPINDLE POISONS
- 2-Methoxyestradiol (2-ME2)
- Bezimidazole Carbamates
- ANG 600 series
- Mebendazole
- CP248/CP461
- HMN-214
- R440
- SDX-103
- T67/T607
LIST OF EXHIBITS
Exhibit 1 - Novel Spindle Poisons and Formulations
|
|
|
|